Biological, immunological and regenerative characteristics of placenta-derived mesenchymal stem cell isolated using a time-gradient attachment method

Stem Cell Research

Volumn 9, Issue 2, 2012, Pages 110-123

  Yuan, Wenji ^a   Zong, Chen ^a   Huang, Yingzhi ^a   Gao, Ying ^b   Shi, Dongyan ^a   Chen, Changsong ^c   Liu, Liyue ^a   Wang, Jinfu ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b Second Hospital of Hangzhou   (China)

^c ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ADIPSIN; BETA1 INTEGRIN; CD11B ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; COLLAGEN TYPE 2; ENDOGLIN; HLA A ANTIGEN; HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEOGLYCAN; STEM CELL FACTOR RECEPTOR; THY 1 ANTIGEN;

ADIPOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DEVELOPMENT; BONE REMODELING; CALVARIA; CELL ADHESION; CELL DENSITY; CELL DIFFERENTIATION; CELL ISOLATION; CELL POPULATION; CELL PROLIFERATION; CELL REGENERATION; CELL STRUCTURE; CHONDROGENESIS; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOGENICITY; IMMUNOMODULATION; IN VITRO STUDY; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MIXED LYMPHOCYTE REACTION; NONHUMAN; PHENOTYPE; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; T LYMPHOCYTE;

ANIMALS; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; CELL SHAPE; FEMALE; HUMANS; IMMUNOMODULATION; MESENCHYMAL STROMAL CELLS; PHENOTYPE; PLACENTA; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; REGENERATION; SKULL; TIME FACTORS; WOUND HEALING;

RATTUS;

EID: 84861948957     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2012.05.003     Document Type: Article

References (57)

1. Ahmad S., Ahmed A. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ. Res. 2004, 95:884-891.
2. Bailo M., Soncini M., Vertua E., Signoroni P.B., Sanzone S., Lombardi G., Arienti D., Calamani F., Zatti D., Paul P., Albertini A., Zorzi F., Cavagnini A., Candotti F., Wengler G.S., Parolini O. Engraftment potential of human amnion and chorion cells derived from term placenta. Transplantation 2004, 78:1439-1448.
3. Baksh D., Davies J.E., Zandstra P.W. Adult human bone marrow derived mesenchymal progenitor cells are capable of adhesion-independent survival and expansion. Exp. Haematol. 2003, 31:723-732.
4. Barry F.P., Murphy J.M., English K., Mahon B.P. Immunogenicity of adult mesenchymal stem cells: lessons from the fetal allograft. Stem Cells Dev. 2005, 14:252-265.
5. Bilic G., Hall H., Renate H., Ochsenbein-Kolble N., Zimmermann R. In vitro lesion repair by human amnion epithelial and mesenchymal cells. Am. J. Obste. Gynecol. 2004, 190:87-92.
6. Campagnoli C., Roberts I.A., Kumar S., Bennett P.R., Bellantuono I., Fisk N.M. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 2001, 98:2396-2402.
7. Caplan A. Mesenchymal stem cells. J. Orthop. Res. 1991, 9:641-650.
8. Clause K.C., Tinney J.P., Liu L.J., Gharaibeh B., Huard J., Kirk J.A., Shroff S.G., Fujimoto K.L., Wagner W.R., Ralphe J.C., Keller B.B., Tobita K. A three-dimensional gel bioreactor for assessment of cardiomyocyte induction in skeletal muscle-derived stem cells. Tissue Eng. Part C Methods 2010, 16:375-385.
9. Crisan M., Yap S., Casteilla L., Chen C.W., Corselli M., Park T.S., Andriolo G., Sun B., Zheng B., Zhang L., Norotte C., Teng P.N., Traas J., Schugar R., Deasy B.M., Badylak S., Buhring H.J., Giacobino J.P., Lazzari L., Huard J., Péault B. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008, 3:301-313.
10. Culling C.F.A. Handbook of Histopathological Techniques 1963, Butterworth, London. 2nd ed.
11. Cybernetics M. Image-Pro Plus - Application Notes 2002, Media Cybernetics, Silver Spring.
12. Dimitrov R., Kyurkchiev D., Timeva T., Yunakova M., Stamenova M., Shterev A., Kyurkchiev S. First-trimester human decidua contains a population of mesenchymal stem cells. Fertil. Steril. 2010, 93:210-219.
13. Di Nicola M., Carlo-Stella C., Magni M., Milanesi M., Longoni P.D., Matteucci P., Grisanti S., Gianni A.M. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002, 99:3838-3843.
14. Ferrari A., Hannouche D., Oudina K., Bourguignon M., Meunier A., Sedel L., Petite H. In vivo tracking of bone marrow fibroblasts with fluorescent carbocyanine dye. J. Biomed. Mater. Res. 2001, 56:361-367.
15. Friedenstein A.J., Gorskaja J.F., Kulagina N.N. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp. Hematol. 1976, 4:267-724.
16. Fukuchi Y., Nakajima H., Sugiyama D., Hirose I., Kitamura T., Tsuji K. Human placenta-derived cells have mesenchymal stem/progenitor cell potential. Stem Cells 2004, 22:649-658.
17. Gharaibeh B., Lu A., Tebbets J., Zheng B., Feduska J., Crisan M., Péault B., Cummins J., Huard J. Isolation of a slowly adhering cell fraction containing stem cells from murine skeletal muscle by the preplate technique. Nat. Protoc. 2008, 3:1501-1509.
18. Haynesworth S.E., Goshima J., Goldberg V.M., Caplan A.I. Characterization of cells with osteogenic potential from human marrow. Bone 1992, 13:81-88.
19. Huang Y.C., Yang Z.M., Chen X.H., Tan M.Y., Wang J., Li X.Q., Xie H.Q., Deng L. Isolation of mesenchymal stem cells from human placental decidua basalis and resistance to hypoxia and serum deprivation. Stem Cell Rev. 2009, 5:247-255.
20. Igura K., Zhang X., Takahashi K., Mitsuru A., Yamaguchi S., Takashi T.A. Isolation and characterization of mesenchymal progenitor cells from chorionic villi of human placenta. Cytotherapy 2004, 6:543-553.
21. Ilancheran S., Michalska A., Peh G., Wallace E.M., Pera M., Manuelpillai U. Stem cells derived from human fetal membranes display multi-lineage differentiation potential. Biol. Reprod. 2007, 77:577-588.
22. In't Anker P.S., Scherjon S.A., Kleijburg-van der Keur C., de Groot-Swings G.M., Claas F.H., Fibbe W.E., Kanhai H.H. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 2004, 22:1338-1345.
23. Ji C.Y., Min F.L., Liang W.Q., Chen Y.H., Pan S.J., Bin L.J., Chen S.H., Wei Z., He T., Gu Y.H., Zhang J.M. Construction of tissue-engineered corpus cavernosum with muscle-derived stem cells and transplantation in vivo. BUJ Int. 2010, 107:1638-1646.
24. Johnstone B., Hering T.M., Caplan A.I., Goldberg V.M., Yoo J.U. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp. Cell Res. 1998, 238:265-272.
25. Krampera M., Glennie S., Dyson J., Scott D., Laylor R., Simpson E., Dazzi F. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 2003, 101:3722-3729.
26. Le Blanc K., Tammik L., Sundberg B., Haynesworth S.E., Ringden O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand. J. Immunol. 2003, 57:11-20.
27. Le Blanc K., Rasmusson I., Sundberg B., Gotherstrom C., Hassan M., Uzunel M., Ringden O. Treatment of severe acute graft-versus host disease with third party haploidentical mesenchymal stem cells. Lancet 2004, 363:1439-1441.
28. Markoff E., Zeitler P., Peleg S., Handwerger S. Characterization of the synthesis and release of prolactin by an enriched fraction of human decidual cells. J. Clin. Endocrinol. Metab. 1983, 56:962-968.
29. Miao Z., Jin J., Chen L., Zhu J., Huang W., Zhao J., Qian H., Zhang X. Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cells. Cell Biol. Int. 2006, 30:681-687.
30. Miki T., Lehmann T., Cai H., Stolz D.B., Strom S.C. Stem cell characteristics of amniotic epithelial cells. Stem Cells 2005, 23:1549-1559.
31. Miki T., Marongiu F., Ellis E.C., Strom S. Isolation of amniotic epithelial stem cells. Curr Protoc Stem Cell Biol 2007, Wiley Online Library.
32. Parolini O., Alviano F., Bagnara G.P., Bilic G., Buhring H.J., Evangelista M., Hennerbichler S., Liu B., Magatti M., Mao N., Miki T., Marongiu F., Nakajima H., Nikaido T., Portmann-Lanz C.B., Sankar V., Soncini M., Stadler G., Surbek D., Takahashi T.A., Redl H., Sakuragawa N., Wolbank S., Zeisberger S., Zisch A., Strom S.C. Concise review: isolation and characterization of cells from human term placenta: outcome of the first international workshop on placenta derived stem cells. Stem Cells 2008, 26:300-311.
33. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
34. Poncelet A.J., Vercruysse J., Saliez A., Gianello P. Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo. Transplantation 2007, 83:783-790.
35. Portmann-Lanz C.B., Schoeberlein A., Huber A., Sager R., Malek A., Holzgreve W., Surbek D.V. Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration. Am. J. Obstet. Gynecol. 2006, 194:664-673.
36. Rasmusson I., Ringden O., Sundberg B., Le Blanc K. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation 2003, 76:1208-1213.
37. Richards R.G., Brar A.K., Frank G.R., Hartman S.M., Jikihara H. Fibroblast cells: induction of prolactin and insulin-like growth factor binding protein-1 expression. Biol. Reprod. 1995, 52:609-615.
38. Rodriguez A.M., Elabd C., Amri E.Z., Ailhaud G., Dani C. The human adipose tissue is a source of multipotent stem cells. Biochimie 2005, 87:125-128.
39. Romanov Y.A., Svintsitskaya V.A., Smirnov V.N. Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-Like cells from umbilical cord. Stem Cells 2003, 21:105-110.
40. Rondelli D., Andrews R.G., Hansen J.A., Ryncarz R., Faerber M.A., Anasetti C. Alloantigen presenting function of normal human CD34+ hematopoietic cells. Blood 1996, 88:2619-2675.
41. Sakuragawa N., Misawa H., Ohsugi K., Kakishita K., Ishii T., Thangavel R., Tohyama J., Elwan M., Yokoyama Y., Okuda O., Arai H., Ogino I., Sato K. Evidence for active acetylcholine metabolism in human amniotic epithelial cells: applicable to intracerebral allografting for neurologic disease. Neurosci. Lett. 1997, 232:53-56.
42. Sarlomo-Rikala M., Kovatich A.J., Barusevicius A., Miettinen M. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod. Pathol. 1998, 11:728-734.
43. Sharifiaghdas F., Taheri M., Moghadasali R. Isolation of human adult stem cells from muscle biopsy for future treatment of urinary incontinence. Cell Mol. Urol. 2011, 8:54-59.
44. Solovjov D., Pluskota E., Plow E.F. Distinct roles for the α and β subunits in the functions of integrin αMβ2. J. Biol. Chem. 2005, 280:1336-1345.
45. Soncini M., Vertua E., Gibelli L., Zorzi F., Denegri M., Albertini A., Wengler G.S., Parolini O. Isolation and characterization of mesenchymal cells from human fetal membranes. J. Tissue Eng. Regen. Med. 2007, 1:296-305.
46. Takashima S., Ise H., Zhao P., Akaike T., Nikaido T. Human amniotic epithelial cells possess hepatocyte-like characteristics and functions. Cell Struct. Funct. 2004, 29:73-84.
47. Terada S., Matsuura K., Enosawa S., Miki M., Hoshika A., Suzuki S., Sakuragawa N. Inducing proliferation of human amniotic epithelial (HAE) cells for cell therapy. Cell Transplant. 2000, 9:701-704.
48. Ueta M., Kweon M.N., Sano Y., Sotozono C., Yamada J., Koizumi N., Kiyono H., Kinoshita S. Immunosuppressive properties of human amniotic membrane for mixed lymphocyte reaction. Clin. Exp. Immunol. 2002, 129:464-470.
49. Wei J.P., Zhang T.S., Kawa S., Aizawa T., Ota M., Akaike T., Kato K., Konishi I., Nikaido T. Human amnion-isolated cells normalize blood glucose in streptozotocin-induced diabetic mice. Cell Transplant. 2003, 12:545-552.
50. Winkler J., Hescheler J., Schinidis A. Embryonic stem cells for basic research and potential clinical applications in cardiology. Biochim. Biophys. Acta 2005, 1740:240-248.
51. Wolbank S., Peterbauer A., Fahrner M., Hennerbichler S., Van Griensven M., Stadler G., Rdel H., Gabriel C. Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue. Tissue Eng. 2007, 3:1173-1183.
52. Yang J.F., Cao C., Wang W., Tong X.M., Shi D.Y., Wu F.B., Zheng Q., Guo C.J., Pan Z.J., Gao C.Y., Wang J.F. Proliferation and osteogenesis of immortalized bone marrow-derived mesenchymal stem cells in porous polylactic glycolic acid scaffolds under perfusion culture. J. Biomed. Mater. Res. A 2010, 93:817-829.
53. Yen B.L., Huang H.I., Chien C.C., Jui H.Y., Ko B.S., Yao M., Shun C.T., Yen M.L., Lee M.C., Chen Y.C. Isolation of multipotent cells from human term placenta. Stem Cells 2005, 23:3-9.
54. Zhang Y., Li C., Jiang X., Zhang S., Wu Y., Liu B., Tang P., Mao N. Human placenta-derived mesenchymal progenitor cells support culture expansion of long-term culture-initiating cells from cord blood CD34+ cells. Exp. Hematol. 2004, 32:657-664.
55. Zhou Q.L., Gong Y.H., Gao C.Y. Microstructure and mechanical properties of poly(L-lactide) scaffolds fabricated by gelatin particle leaching method. J. Appl. Polymer Sci. 2005, 98:1373-1379.
56. Zong C., Xue D.T., Yuan W.J., Wang W., Shen D., Tong X.M., Shi D.Y., Liu L.Y., Zheng Q., Gao C.Y., Wang J.F. Reconstruction of rat calvarial defects with human mesenchymal stem cells and osteoblast-like cells in poly-lactic-co-glycolic acid scaffolds. Euro. Cell Mater. 2010, 20:109-120.
57. Zsarnovszky A., Le H.H., Wang H.S., Belcher S.M. Ontogeny of rapid estrogen-mediated extracellular signal-regulated kinase signaling in the rat cerebellar cortex: potent nongenomic agonist and endocrine disrupting activity of the xenoestrogen bisphenol A. Endocrinology 2005, 146:5388-5396.